Intra-arterial combination therapy for experimental acute ischemic stroke

Area of Science:

• Neuroscience
• Pharmacology
• Ischemic Stroke Research

Background:

• Acute ischemic stroke causes significant global mortality and morbidity.
• Current reperfusion therapies do not fully protect brain tissue from ischemic injury.
• Targeting the ischemic cascade with neuroprotective agents is a critical unmet need.

Purpose of the Study:

• To develop and evaluate a combination neuroprotective therapy administered intra-arterially.
• To assess the safety and efficacy of combining verapamil and lubeluzole post-recanalization.
• To investigate the potential synergistic benefits of this combination in an acute ischemic stroke model.

Main Methods:

• A transient middle cerebral artery occlusion model was used in C57Bl/6J male mice.
• Intra-arterial administration of verapamil and lubeluzole combination therapy post-recanalization.
• Assessment of physiological parameters, infarct volume, neuronal health, astrogliosis, and functional outcomes.

Main Results:

• Combination therapy demonstrated no adverse physiological effects (heart rate, blood pressure).
• Significant reductions in infarct volume, improved neuronal health, and modulated astrogliosis were observed.
• While not statistically significant, a trend towards improved motor function recovery was noted.

Conclusions:

• Intra-arterial administration of verapamil and lubeluzole is safe and feasible following ischemic stroke recanalization.
• The combination therapy shows promise in mitigating ischemic brain tissue damage.
• Further investigation is warranted to optimize this therapeutic approach and confirm functional benefits.